Nonproliferative retinopathy

Nonproliferative retinopathy

Retinopathy without the growth of new blood vessels.
Mentioned in: Retinopathies
References in periodicals archive ?
Treatment includes laser photocoagulation therapy for high-risk nonproliferative retinopathy or proliferative retinopathy, or intravitreal injections of antivascular endothelial growth factor agents for central-involved diabetic macular edema.
The risk model was derived and tested based on data from 14,000 patients with no or mild nonproliferative retinopathy treated in the Gloucestershire area.
Within 7-8 months after diagnosis, 14% already had nonproliferative retinopathy.
By 2002 she developed nonproliferative retinopathy and proteinuria.
In the study by Moss et al, proliferative retinopathy was detected in 135 patients (79%), nonproliferative retinopathy in 32 (19%), and no retinopathy in 3 (2%).
The study population included patients in a primary intervention cohort who had diabetes for 1-5 years with an albumin excretion rate of less than 40 mg per 24 hours and no retinopathy and those in a secondary intervention cohort with a 1-to 15-year history of diabetes, an albumin excretion rate of 200 mg or less per 24 hours, and no more than moderate nonproliferative retinopathy, he noted.
By the end of the study, intensive therapy had reduced the development of retinopathy by 76%, the progression of retinopathy by 54%, and the development of proliferative or severe nonproliferative retinopathy by 47%, compared with conventional therapy.